SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (1756)1/15/1998 9:27:00 PM
From: Anaxagoras  Read Replies (2) of 7041
 
I respect the anonymity of your sources. I'm just trying to get to the bottom of things in order to make money. I'm not on a mission. I don't care which way I make money on this. But I still think the balance lies in favor of Zonagen and the company line- no joke. But again, I have no ego on this one- I'll short it at the drop of a hat if I see good reason to expect it to go down.

<<Schering Plough was misled about the formulation and the patent app!>>

Again, I understand you are reluctant to identify by name the individuals with whom you spoke, but could you give a little colour as to the points in which they were allegedly misled? This seems to be different than what you said earlier, i.e. that just the marketing guys were in on the agreement, and no discussion whatsoever centered on the formulation of Vasomax. Now it seems you are suggesting that instead SGP was presented with information that was false- what was this (mis-) information?

Thank you.

Anaxagoras
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News